AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

NCT07640737 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroendocrine (NE) Tumors
Advanced NET of GI Origin

Interventions

DRUG: AUR103 Calcium

Sponsor

Aurigene Discovery Technologies Limited